These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful? McDougall IR J Endocrinol Invest; 2001 Mar; 24(3):194-8. PubMed ID: 11314751 [No Abstract] [Full Text] [Related]
6. Treatment of iodine negative, thyroglobulin positive, thyroid cancer patients: do we miss the target when we shoot in the dark? Kabasakal L Nucl Med Commun; 2003 Jul; 24(7):739-41. PubMed ID: 12813190 [No Abstract] [Full Text] [Related]
7. Disappearance rate of endogenously radioiodinated thyroglobulin and thyroxine after radioiodine treatment. Jeevanram RK; Shah DH; Sharma SM; Ganatra RD Cancer; 1982 Jun; 49(11):2281-4. PubMed ID: 7074544 [TBL] [Abstract][Full Text] [Related]
8. Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation. Matrone A; Gambale C; Piaggi P; Viola D; Giani C; Agate L; Bottici V; Bianchi F; Materazzi G; Vitti P; Molinaro E; Elisei R J Clin Endocrinol Metab; 2017 Mar; 102(3):893-902. PubMed ID: 27929713 [TBL] [Abstract][Full Text] [Related]
9. [Iodine uptake in the chest in the follow-up of well-differentiated thyroid cancer]. García Alonso MP; Balsa Bretón MA; Paniagua Correa C; Castillejos Rodríguez L; Penín González FJ; Elviro Peña R; Ortega Valle A; Mariana Monguía A; Vásquez Tineo SI; Mendoza Paulini A; Pey Illera C Rev Esp Med Nucl; 2011; 30(1):24-8. PubMed ID: 20863596 [TBL] [Abstract][Full Text] [Related]
10. Extensive lymph node metastases found by (18)F-FDG-PET/CT in a patient with diffuse sclerosing variant of papillary thyroid carcinoma. Xu YH; Song HJ; Qiu ZL; Luo QY Hell J Nucl Med; 2011; 14(2):188-9. PubMed ID: 21761030 [No Abstract] [Full Text] [Related]
11. Whole body scintigram with 131I before and immediately after the ablation or tumor dose in patients with differentiated thyroid carcinoma and the effect of endogenous stimulation of thyrostimulating hormone on thyroglobulin in same patients. Malesevic M; Stefanovic L; Popovic S; Prvulovic M; Selir Z; Milkovic L Radiobiol Radiother (Berl); 1987; 28(5):651-3. PubMed ID: 3441615 [No Abstract] [Full Text] [Related]
12. Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131? Hindié E; Zanotti-Fregonara P; Duron F; Keller I; Bouchard P; Devaux JY Clin Endocrinol (Oxf); 2007 Mar; 66(3):329-34. PubMed ID: 17302864 [TBL] [Abstract][Full Text] [Related]
13. Ruling out 131I ablation in low-risk differentiated thyroid carcinoma basing on thyroglobulin measurement. Giovanella L; Verburg FA Thyroid; 2011 Jul; 21(7):809-10; author reply 811-2. PubMed ID: 21615306 [No Abstract] [Full Text] [Related]
14. Use of fractionated doses of iodine-131 for ablation of thyroid remnants. Wang SJ; Liu TJ Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jul; 65(7):336-40. PubMed ID: 12365652 [TBL] [Abstract][Full Text] [Related]
15. Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scans. Clark OH; Hoelting T Thyroid; 1994; 4(4):501-5. PubMed ID: 7711516 [TBL] [Abstract][Full Text] [Related]
16. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer. de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550 [TBL] [Abstract][Full Text] [Related]
17. 131I therapy for elevated thyroglobulin levels. Schlumberger M; Mancusi F; Baudin E; Pacini F Thyroid; 1997 Apr; 7(2):273-6. PubMed ID: 9133699 [TBL] [Abstract][Full Text] [Related]
18. Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases. Kabasakal L; Selçuk NA; Shafipour H; Ozmen O; Onsel C; Uslu I Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1500-4. PubMed ID: 15232654 [TBL] [Abstract][Full Text] [Related]
19. Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy? Giovanella L; Avram AM; Clerc J; Hindié E; Taïeb D; Verburg FA Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2155-2158. PubMed ID: 30062605 [No Abstract] [Full Text] [Related]
20. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer. Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]